Judo Bio is a Biotech company based in Cambridge, MA. It has raised $100M in total funding. Latest round: Series A.
Judo Bio funding overview
Judo Bio is a Biotech company based in Cambridge, MA. Judo Bio has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for Judo Bio runs through 2024; nothing later has been disclosed. Investors on record include Atlas Venture, The Column Group, Droia Ventures, Digitalis Ventures, Euclidean Capital, Alexandria Venture Investments and 1 others. 7 distinct backers are named across the disclosed rounds.
Judo Bio has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Judo Bio?
Atlas Venture, The Column Group, Droia Ventures, Digitalis Ventures, Euclidean Capital, Alexandria Venture Investments are named among the investors backing Judo Bio.
What was the latest Judo Bio funding round?
The most recent disclosed round is a Series A, announced in October 2024.
Where is Judo Bio based?
Judo Bio is based in Cambridge, MA.
What sector does Judo Bio operate in?
Judo Bio is tracked under Biotech from Cambridge, MA, with $100M in disclosed funding.
When did Judo Bio last raise?
The last disclosed Judo Bio round closed in October 2024 at Series A.
Every Judo Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
